TY - JOUR
T1 - Multi-omic insights into Parkinson's Disease
T2 - From genetic associations to functional mechanisms
AU - Schilder, Brian M.
AU - Navarro, Elisa
AU - Raj, Towfique
N1 - Funding Information:
This work was supported by grants awarded to TR by the Michael J. Fox Foundation (Grant # 14899 and # 16743 ) and US National Institutes of Health ( NIH NIA R01-AG054005 , NINDS R01-NS116006 and NINDS U01-NS120256 ). The author BMS was additionally supported by the UK Dementia Research Institute which receives its funding from UK DRI Ltd , funded by the UK Medical Research Council , Alzheimer's Society and Alzheimer's Research UK .
Publisher Copyright:
© 2021 The Authors
PY - 2022/2
Y1 - 2022/2
N2 - Genome-Wide Association Studies (GWAS) have elucidated the genetic components of Parkinson's Disease (PD). However, because the vast majority of GWAS association signals fall within non-coding regions, translating these results into an interpretable, mechanistic understanding of the disease etiology remains a major challenge in the field. In this review, we provide an overview of the approaches to prioritize putative causal variants and genes as well as summarise the primary findings of previous studies. We then discuss recent efforts to integrate multi-omics data to identify likely pathogenic cell types and biological pathways implicated in PD pathogenesis. We have compiled full summary statistics of cell-type, tissue, and phentoype enrichment analyses from multiple studies of PD GWAS and provided them in a standardized format as a resource for the research community (https://github.com/RajLabMSSM/PD_omics_review). Finally, we discuss the experimental, computational, and conceptual advances that will be necessary to fully elucidate the effects of functional variants and genes on cellular dysregulation and disease risk.
AB - Genome-Wide Association Studies (GWAS) have elucidated the genetic components of Parkinson's Disease (PD). However, because the vast majority of GWAS association signals fall within non-coding regions, translating these results into an interpretable, mechanistic understanding of the disease etiology remains a major challenge in the field. In this review, we provide an overview of the approaches to prioritize putative causal variants and genes as well as summarise the primary findings of previous studies. We then discuss recent efforts to integrate multi-omics data to identify likely pathogenic cell types and biological pathways implicated in PD pathogenesis. We have compiled full summary statistics of cell-type, tissue, and phentoype enrichment analyses from multiple studies of PD GWAS and provided them in a standardized format as a resource for the research community (https://github.com/RajLabMSSM/PD_omics_review). Finally, we discuss the experimental, computational, and conceptual advances that will be necessary to fully elucidate the effects of functional variants and genes on cellular dysregulation and disease risk.
KW - Genome-wide association study (GWAS)
KW - Meta-analysis
KW - Multi-omics
KW - Neurodegeneration
KW - Parkinson's Disease
KW - Phenome
KW - Quantitative trait loci (QTL)
UR - http://www.scopus.com/inward/record.url?scp=85121638182&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2021.105580
DO - 10.1016/j.nbd.2021.105580
M3 - Review article
C2 - 34871738
AN - SCOPUS:85121638182
SN - 0969-9961
VL - 163
JO - Neurobiology of Disease
JF - Neurobiology of Disease
M1 - 105580
ER -